These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12652109)

  • 1. Vitamins, antioxidants and endothelial function in coronary artery disease.
    Hornig B
    Cardiovasc Drugs Ther; 2002 Sep; 16(5):401-9. PubMed ID: 12652109
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase.
    Hornig B; Landmesser U; Kohler C; Ahlersmann D; Spiekermann S; Christoph A; Tatge H; Drexler H
    Circulation; 2001 Feb; 103(6):799-805. PubMed ID: 11171786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular health: the emerging appreciation of the endothelium.
    Talley JD
    J Ark Med Soc; 1997 Feb; 93(9):454-5. PubMed ID: 9046759
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease].
    Rocha E
    Rev Port Cardiol; 2000 Dec; 19(12):1319-20. PubMed ID: 11220127
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac Syndrome X: role of superoxide dismutase activity.
    Pizzi C; Manfrini O; Fontana F; Bugiardini R
    Circulation; 2004 Jan; 109(1):53-8. PubMed ID: 14699004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Coronary atherosclerosis and vascular endothelial dysfunction].
    Nishinaga M
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():75-9. PubMed ID: 12734956
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of coronary endothelial function on the progression of cardiac transplant-associated arteriosclerosis: effect of anti-oxidant vitamins C and E.
    Behrendt D; Beltrame J; Hikiti H; Wainstein M; Kinlay S; Selwyn AP; Ganz P; Fang JC
    J Heart Lung Transplant; 2006 Apr; 25(4):426-33. PubMed ID: 16563973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endothelial dysfunction and angiotensin-converting enzyme inhibitors in coronary disease].
    Mélon P
    Rev Med Liege; 1998 Jun; 53(6):353-4. PubMed ID: 9713215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nitrous oxide and atherosclerosis. Pharmacotherapy of atherosclerosis and nitrous oxide].
    Markov KhM
    Kardiologiia; 2010; 50(12):69-77. PubMed ID: 21591396
    [No Abstract]   [Full Text] [Related]  

  • 10. Endothelial dysfunction: the role and impact of the renin-angiotensin system.
    Lüscher TF
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i20-2:discussion i50. PubMed ID: 10956315
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options.
    Britten MB; Zeiher AM; Schächinger V
    J Intern Med; 1999 Apr; 245(4):315-27. PubMed ID: 10356593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to reduce oxidative stress in cardiovascular disease.
    Hamilton CA; Miller WH; Al-Benna S; Brosnan MJ; Drummond RD; McBride MW; Dominiczak AF
    Clin Sci (Lond); 2004 Mar; 106(3):219-34. PubMed ID: 14733610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function.
    Kinlay S; Behrendt D; Fang JC; Delagrange D; Morrow J; Witztum JL; Rifai N; Selwyn AP; Creager MA; Ganz P
    J Am Coll Cardiol; 2004 Feb; 43(4):629-34. PubMed ID: 14975474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease.
    Gokce N; Keaney JF; Frei B; Holbrook M; Olesiak M; Zachariah BJ; Leeuwenburgh C; Heinecke JW; Vita JA
    Circulation; 1999 Jun; 99(25):3234-40. PubMed ID: 10385496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoring the dysfunctional endothelium.
    Osto E; Coppolino G; Volpe M; Cosentino F
    Curr Pharm Des; 2007; 13(10):1053-68. PubMed ID: 17430168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors, calcium blockers, estrogen and antioxidants in secondary prevention of coronary disease.
    Vogel R
    Can J Cardiol; 1998 Jul; 14 Suppl D():8D-10D. PubMed ID: 9713419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and endothelial dysfunction: therapeutic implications.
    Gori T; Münzel T
    Ann Med; 2011 Jun; 43(4):259-72. PubMed ID: 21284528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction and coronary risk reduction.
    Charo S; Gokce N; Vita JA
    J Cardiopulm Rehabil; 1998; 18(1):60-7. PubMed ID: 9494884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and the role of antioxidants in cardiovascular risk reduction.
    Schoonover LL
    Prog Cardiovasc Nurs; 2001; 16(1):30-2. PubMed ID: 11252875
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies.
    Förstermann U
    Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):338-49. PubMed ID: 18461048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.